| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 654849 | 06370011 | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 5 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370011/06370011_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370011/06370011_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658408, 663429 | View Edit Delete | |||||||||||
| 654850 | 06370019 | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE 10 mg/160 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06370019/06370019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06370019/06370019_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2007-02-08 | 1 | 1 | 1 | 2007-02-08 | 2014-03-17 | 0 | 2013-11-12 | 658409, 663430 | View Edit Delete | |||||||||||
| 654851 | 09569002 | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569002/09569002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569002/09569002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664335 | View Edit Delete | |||||||||||
| 654852 | 09569014 | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569014/09569014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569014/09569014_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664336 | View Edit Delete | |||||||||||
| 654853 | 09569026 | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569026/09569026_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569026/09569026_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664337 | View Edit Delete | |||||||||||
| 654854 | 09569038 | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | EXFORGE HCT 10 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 160 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09569038/09569038_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09569038/09569038_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2009-12-15 | 1 | 1 | 1 | 2009-12-15 | 2014-03-17 | 0 | 2011-02-24 | 664338 | View Edit Delete | |||||||||||
| 655134 | 62024 | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA | VOLTAREN RETARD 75 mg COMPRIMIDOS DE LIBERACION MODIFICADA , 40 comprimidos | 75 mg | 5 | 40 | 10 | 40 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62024/62024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62024/62024_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 657353 | 62206 | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CO-DIOVAN 80 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (AL/PVC/PVDC) | 80 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos (AL/PVC/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62206/62206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62206/62206_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 0 | 2011-10-06 | View Edit Delete | ||||||||||||
| 656800 | 68618 | LOSARTAN UXA 50 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN UXA 50 mg, COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68618/68618_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68618/68618_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 20478 | UXA FARMA S.A. | 2007-03-28 | 1 | 1 | 1 | 2007-03-28 | 2007-03-28 | 1 | 2011-10-03 | 658768 | View Edit Delete | |||||||||||
| 656124 | 48905 | ALGI-MABO 500 MG CÁPSULAS DURAS | ALGI-MABO 500 MG CÁPSULAS DURAS , 20 cápsulas | 500 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/48905/48905_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48905/48905_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 1970-02-01 | 1 | 1 | 1 | 1970-02-01 | 1998-06-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656290 | 68128 | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG | ACIDO ALENDRONICO SEMANAL MABO 70 mg COMPRIMIDOS EFG, 4 comprimidos | 70 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68128/68128_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68128/68128_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2006-11-02 | 1 | 1 | 1 | 2006-11-02 | 2006-11-02 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 656087 | 67019 | CETIRIZINA SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | CETIRIZINA SANDOZ 10 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67019/67019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67019/67019_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2005-09-05 | 1 | 1 | 1 | 2005-09-05 | 2006-09-28 | 1 | 2011-11-15 | 652083 | View Edit Delete | |||||||||||
| 656153 | 68077 | FUROSEMIDA SANDOZ 40 mg COMPRIMIDOS EFG | FUROSEMIDA SANDOZ 40 mg COMPRIMIDOS EFG, 30 comprimidos | 40 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68077/68077_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68077/68077_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2006-10-10 | 1 | 1 | 1 | 2006-10-10 | 2006-10-10 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 654842 | 73432 | CAPENON HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73432/73432_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73432/73432_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-03-03 | 1 | 1 | 1 | 2011-03-03 | 2014-02-03 | 1 | 2014-01-02 | 678584 | View Edit Delete | |||||||||||
| 654843 | 73435 | CAPENON HCT 40 mg/10 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON HCT 40 mg/10 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73435/73435_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73435/73435_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-23 | 1 | 1 | 1 | 2011-02-23 | 2014-02-03 | 1 | 2014-01-02 | 678592 | View Edit Delete | |||||||||||
| 654844 | 73452 | SEVIKAR HCT 40 mg/10 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEVIKAR HCT 40 mg/10 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/10 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73452/73452_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73452/73452_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-23 | 1 | 1 | 1 | 2011-02-23 | 2014-03-01 | 1 | 2014-01-02 | 678652 | View Edit Delete | |||||||||||
| 654845 | 73454 | SEVIKAR HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEVIKAR HCT 40 mg/10 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/10 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73454/73454_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73454/73454_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-23 | 1 | 1 | 1 | 2011-02-23 | 2014-03-01 | 1 | 2014-01-02 | 678661 | View Edit Delete | |||||||||||
| 656111 | 68057 | BICALUTAMIDA PENSA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BICALUTAMIDA PENSA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68057/68057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68057/68057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2006-10-04 | 1 | 1 | 1 | 2006-10-04 | 2006-10-04 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 656289 | 67523 | DOMPERIDONA PENSA 10 mg COMPRIMIDOS EFG | DOMPERIDONA PENSA 10 mg COMPRIMIDOS EFG , 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67523/67523_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67523/67523_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2006-01-31 | 1 | 1 | 1 | 2006-01-31 | 2006-11-06 | 1 | 2011-07-11 | 653714 | View Edit Delete | |||||||||||
| 656341 | 68154 | LOSARTAN PENSA INICIO 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN PENSA INICIO 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 7 comprimidos | 12,5 mg | 5 | 7 | 10 | 7 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68154/68154_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68154/68154_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2006-11-08 | 1 | 1 | 1 | 2006-11-08 | 2006-11-08 | 1 | 2011-06-16 | View Edit Delete |
Page 122 of 1036, showing 20 records out of 20709 total, starting on record 2421, ending on 2440